DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neupogen (Filgrastim) - Deep Vein Thrombosis - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Deep Vein Thrombosis (44)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neupogen (Filgrastim) where reactions include deep vein thrombosis. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 44   Next >>

Possible Neupogen side effects in 45 year old female

Reported by a physician from India on 2012-07-20

Patient: 45 year old female

Reactions: Thrombocytosis, Deep Vein Thrombosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Neupogen

Other drugs received by patient: Aripiprazole



Possible Neupogen side effects in

Reported by a physician from United Kingdom on 2012-05-02

Patient:

Reactions: Abdominal Pain, Pneumonia Aspiration, Oral Candidiasis, Dizziness, Constipation, Deep Vein Thrombosis

Drug(s) suspected as cause:
Neupogen



Possible Neupogen side effects in

Reported by a physician from United Kingdom on 2012-05-02

Patient:

Reactions: Oral Candidiasis, Liver Function Test Abnormal, Pulmonary Embolism, Deep Vein Thrombosis

Drug(s) suspected as cause:
Neupogen



Possible Neupogen side effects in 68 year old male

Reported by a physician from Denmark on 2012-04-06

Patient: 68 year old male, weighing 81.0 kg (178.2 pounds)

Reactions: Klebsiella Infection, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1500 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-22

Prednisone TAB
    Dosage: 100 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-22

Rituximab
    Dosage: 800 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-22

Doxorubicin HCL
    Dosage: 100 unk, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-22

Neupogen
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-23

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-22



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-03

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vincristine Sulfate
    Dosage: 2 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Doxorubicin HCL
    Dosage: 110 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-12-02

Cyclophosphamide
    Dosage: 1600 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-30

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Agranulocytosis, Sepsis, Neutropenia, Deep Vein Thrombosis, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 110 mg milligram(s),intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Cyclophosphamide
    Dosage: 1600 mg milligram(s)intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg milligram(s)intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Vincristine Sulfate
    Dosage: 2 mg milligram(s), intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg milligram(s)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg milligram(s) ( 1 day ) oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Clozapine
    Dosage: 200 mg milligram(s) ( 1 day ) oral
    Indication: Schizophrenia
    Start date: 2011-12-02

Other drugs received by patient: Citalopram Hydrobromide



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-27

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1600 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Vincristine Sulfate
    Dosage: 2 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-12-02

Neupogen
    Dosage: 800 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Other drugs received by patient: Amisulpride; Pirenzepine; Citalopram



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-20

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutrophil Count Increased, Neutropenia, Deep Vein Thrombosis, White Blood Cell Count Increased, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: 60 mg mgilligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg milligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Vincristine Sulfate
    Dosage: 2 mg milligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Cyclophosphamide
    Dosage: 1600 mgilligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg milligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg mgilligram(s), 1 day, oral
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Other drugs received by patient: Citalopram Hydrobromide; (Amisulpride); (Pirenzepine)



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-15

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1600 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-12-02

Vincristine Sulfate
    Dosage: 2 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Other drugs received by patient: Amisulpride; Pirenzepine; Citalopram



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-12

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Cyclophosphamide
    Dosage: 1600 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Vincristine Sulfate
    Dosage: 2 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-12-02

Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-02

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vincristine Sulfate
    Dosage: 2 mg milligram(s), unknown, intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg milligram(s), 1 day, oral, 200 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Clozapine
    Dosage: 200 mg milligram(s), 1 day, oral, 200 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-12-02

Doxorubicin HCL
    Dosage: 110 mg milligram(s), unknown, intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg milligram(s), unknown, intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Cyclophosphamide
    Dosage: 1600 milligram(s), unknown, intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg milligram(s), unknown, unknown
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-29

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Deep Vein Thrombosis, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clozapine
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-01-12

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Prednisolone
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Clozapine
    Start date: 2011-12-02

Neupogen
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-23

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-09-22

Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram Hydrobromide



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-23

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Neupogen
    Dosage: 800 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Vincristine Sulfate
    Dosage: 2 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Cyclophosphamide
    Dosage: 1600 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-12-02

Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine



Possible Neupogen side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-02-23

Patient: 65 year old male, weighing 74.0 kg (162.8 pounds)

Reactions: Lung Infection, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neupogen
    Dosage: 06 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-25

Vinblastine Sulfate
    Dosage: unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-12-14

Doxorubicin HCL
    Dosage: 98.5 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-24

Rituximab
    Dosage: 700 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-24

Prednisone TAB
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-24

Vincristine Sulfate
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-24

Cyclophosphamide
    Dosage: 1463 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-24

Doxorubicin HCL
    Start date: 2010-12-16

Vincristine Sulfate
    Start date: 2010-12-16

Other drugs received by patient: Morphine; Oxycodone HCL; Metoprolol; Pantoprazole



Possible Neupogen side effects in 65 year old male

Reported by a physician from Denmark on 2012-02-22

Patient: 65 year old male, weighing 74.0 kg (162.8 pounds)

Reactions: Lung Infection, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 11.8 mg, unk
    Start date: 2010-12-16

Rituximab
    Dosage: 700 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-24

Vinblastine Sulfate
    Dosage: unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-12-14

Neupogen
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-25

Prednisone TAB
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-24

Doxorubicin HCL
    Dosage: 97.5 mg, unk
    Start date: 2010-12-16

Cyclophosphamide
    Dosage: 1463 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-24

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-24
    End date: 2010-12-01

Doxorubicin HCL
    Dosage: 98.5 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-24

Other drugs received by patient: Oxycodone; Morphine; Pantoprazole; Metoprolol



Possible Neupogen side effects in 42 year old male

Reported by a pharmacist from United Kingdom on 2012-02-21

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 110 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Neupogen
    Dosage: 800 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Prednisolone
    Dosage: 60 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2011-12-02

Vincristine
    Dosage: 2 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Cyclophosphamide
    Dosage: 1600 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram Hydrobromide



Possible Neupogen side effects in 68 year old male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-02-10

Patient: 68 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Neutropenia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1350 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-31

Vincristine Sulfate
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-31

Neupogen
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-09-01

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-31

Doxorubicin HCL
    Dosage: 90 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-31

Rituximab
    Dosage: 650 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-31

Other drugs received by patient: Allopurinol; Acyclovir; Ondansetron; Bactrim



Possible Neupogen side effects in male

Reported by a physician from Denmark on 2012-02-08

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1350 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-31

Rituximab
    Dosage: 650 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-31

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-31

Doxorubicin HCL
    Dosage: 90 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-31

Neupogen
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-09-01

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-31

Other drugs received by patient: Allopurinol; Ondansetron; Bactrim; Acyclovir



Possible Neupogen side effects in 55 year old male

Reported by a physician from Netherlands on 2012-02-07

Patient: 55 year old male

Reactions: Deep Vein Thrombosis, Erysipelas

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-15

Rituximab
    Dosage: 750 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-15

Neupogen
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-16

Cyclophosphamide
    Dosage: 1500 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-15

Doxorubicin HCL
    Dosage: 100 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-15

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-15



Possible Neupogen side effects in 68 year old male

Reported by a physician from Denmark on 2012-02-02

Patient: 68 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neupogen
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-09-01

Cyclophosphamide
    Dosage: 1350 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-31

Prednisone TAB
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-31

Rituximab
    Dosage: 650 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-31

Doxorubicin HCL
    Dosage: 90 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-31

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-31

Other drugs received by patient: Acyclovir; Bactrim; Allopurinol; Ondansetron



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-30

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Agranulocytosis, Neutropenia, Diffuse Large B-Cell Lymphoma, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1600 mg milligram(s), intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Vincristine Sulfate
    Dosage: 2 mg milligram(s) intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg milligram(s)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg milligram(s), intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Clozapine
    Dosage: 200 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-12-02

Clozapine
    Dosage: 200 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Doxorubicin HCL
    Dosage: 110 mg milligram(s), intravenous (not otherwise specified)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Other drugs received by patient: (Pirenzeprine); (Citalopram); (Amisulpride)



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-26

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Prednisolone
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Neupogen
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-23

Clozapine
    Start date: 2011-12-02

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-09-22

Clozapine
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-01-12

Other drugs received by patient: Amisulpride; Citalopram Hydrobromide; Pirenzepine



Possible Neupogen side effects in 42 year old male

Reported by a pharmacist from United Kingdom on 2012-01-23

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: 60 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2011-12-02

Cyclophosphamide
    Dosage: 1600 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Vincristine
    Dosage: 2 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-20

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Sepsis, Bone Marrow Failure, non-Hodgkin's Lymphoma, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1600 mg milligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg milligram(s)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Doxorubicin HCL
    Dosage: 2 mg milligram(s), unknown intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Vincristine Sulfate
    Dosage: 2 mg milligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg milligram(s)
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Pirenzepine; Citalopram Hydrobromide; Amisulpride



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-20

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 110 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Cyclophosphamide
    Dosage: 1600 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Vincristine Sulfate
    Dosage: 2 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Prednisolone
    Dosage: 60 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-12-02

Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-17

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Cyclophosphamide
    Dosage: 1600 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Vincristine Sulfate
    Dosage: 2 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2011-12-02

Neupogen
    Dosage: 800 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Prednisolone
    Dosage: 60 mg, daily
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Other drugs received by patient: Amisulpride; Pirenzepine; Citalopram



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-16

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Neupogen
    Dosage: 800 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Cyclophosphamide
    Dosage: 1600 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Vincristine
    Dosage: 2 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Doxorubicin HCL
    Dosage: 110 mg, one time dose
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2011-12-02

Clozapine
    Dosage: 200 mg, bid
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Other drugs received by patient: Amisulpride; Citalopram; Pirenzepine



Possible Neupogen side effects in male

Reported by a physician from Denmark on 2012-01-09

Patient: male, weighing 74.0 kg (162.8 pounds)

Reactions: Lung Infection, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-24

Vincristine
    Start date: 2010-12-16

Prednisone TAB
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-24

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-02-15

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-24

Neupogen
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-25

Doxorubicin HCL
    Start date: 2010-09-24

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-09-24

Doxorubicin HCL
    Start date: 2010-12-16

Vinblastine Sulfate
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2010-12-14

Other drugs received by patient: Morphine; Oxycodone HCL; Metoprolol Succinate; Pantoprazole



Possible Neupogen side effects in 42 year old male

Reported by a pharmacist from United Kingdom on 2012-01-04

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Neupogen
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-23

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-11-22

Clozapine
    Start date: 2011-12-02

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma Stage II
    Start date: 2011-09-22

Clozapine
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-01-12

Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram



Possible Neupogen side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-12-30

Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)

Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Deep Vein Thrombosis, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clozapine
    Dosage: 200 mg milligram(s), 1 day, oral; 200 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-12-09

Clozapine
    Dosage: 200 mg milligram(s), 1 day, oral; 200 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-09-15
    End date: 2011-12-01

Vincristine Sulfate
    Dosage: 2 mg milligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Cyclophosphamide
    Dosage: 1600 mg milligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Prednisolone
    Dosage: 60 mg milligram(s)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-22

Neupogen
    Dosage: 800 mg milligram(s), intravenous
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-11-23

Other drugs received by patient: Pirenzepine; Citalopram Hydrobromide; Amisulpride



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017